Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies

Abstract

Japanese encephalitis virus (JEV), closely related to dengue, Zika, yellow fever and West Nile viruses, remains neglected and not well characterized1. JEV is the leading causative agent of encephalitis, and is responsible for thousands of deaths each year in Asia. Humoral immunity is essential for protecting against flavivirus infections and passive immunization has been demonstrated to be effective in curing disease2,3. Here, we demonstrate that JEV-specific monoclonal antibodies, 2F2 and 2H4, block attachment of the virus to its receptor and also prevent fusion of the virus. Neutralization of JEV by these antibodies is exceptionally potent and confers clear therapeutic benefit in mouse models. A single 20 μg dose of these antibodies resulted in 100% survival and complete clearance of JEV from the brains of mice. The 4.7 Å and 4.6 Å resolution cryo-electron microscopy structures of JEV–2F2-Fab and JEV–2H4-Fab complexes, together with the crystal structure of 2H4 Fab and our recent near-atomic structure of JEV4, unveil the nature and location of epitopes targeted by the antibodies. Both 2F2 and 2H4 Fabs bind quaternary epitopes that span across three adjacent envelope proteins. Our results provide a structural and molecular basis for the application of 2F2 and 2H4 to treat JEV infection.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: 2F2 and 2H4 are JEV-specific neutralizing antibodies of therapeutic value.
Fig. 2: Cryo-EM structures of JEV–2F2-Fab and JEV–2H4-Fab.
Fig. 3: Interactions between 2H4 Fab and three E proteins.
Fig. 4: 2F2 and 2H4 neutralize JEV by inhibiting attachment and fusion of JEV.

References

  1. 1.

    Campbell, G. L. et al. Estimated global incidence of Japanese encephalitis: a systematic review. B. World Health Organ. 89, 766–774 (2011).

    Article  Google Scholar 

  2. 2.

    Diamond, M. S., Shrestha, B., Mehlhop, E., Sitati, E. & Engle, M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16, 259–278 (2003).

    CAS  Article  Google Scholar 

  3. 3.

    Roehrig, J. T., Staudinger, L. A., Hunt, A. R., Mathews, J. H. & Blair, C. D. Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann. NY Acad. Sci. 951, 286–297 (2001).

    CAS  Article  Google Scholar 

  4. 4.

    Wang, X. et al. Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability. Nat. Commun. 8, 14 (2017).

    Article  Google Scholar 

  5. 5.

    Zhang, M. J., Wang, M. J., Jiang, S. Z. & Ma, W. Y. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J. Med. Virol. 29, 133–138 (1989).

    CAS  Article  Google Scholar 

  6. 6.

    Zhang, X. et al. Dengue structure differs at the temperatures of its human and mosquito hosts. Proc. Natl Acad. Sci. USA 110, 6795–6799 (2013).

    CAS  Article  Google Scholar 

  7. 7.

    Scheres, S. H. & Chen, S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods 9, 853–854 (2012).

    CAS  Article  Google Scholar 

  8. 8.

    Simhaev, L., McCarty, N. A., Ford, R. C. & Senderowitz, H. Molecular dynamics flexible fitting simulations identify new models of the closed state of the cystic fibrosis transmembrane conductance regulator protein. J. Chen. Inf. Model. 57, 1932–1946 (2017).

    CAS  Article  Google Scholar 

  9. 9.

    Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix. refine. Acta Crystallogr. D 68, 352–367 (2012).

    CAS  Article  Google Scholar 

  10. 10.

    Pierson, T. C. & Kielian, M. Flaviviruses: braking the entering. Curr. Opin. Virol. 3, 3–12 (2013).

    CAS  Article  Google Scholar 

  11. 11.

    Kuhn, R. J. et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717–725 (2002).

    CAS  Article  Google Scholar 

  12. 12.

    Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313–319 (2004).

    CAS  Article  Google Scholar 

  13. 13.

    Fibriansah, G. et al. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat. Commun. 6, 6341 (2015).

    CAS  Article  Google Scholar 

  14. 14.

    Fibriansah, G. et al. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science 349, 88–91 (2015).

    CAS  Article  Google Scholar 

  15. 15.

    Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109–113 (2015).

    CAS  Article  Google Scholar 

  16. 16.

    Teoh, E. P. et al. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci. Transl. Med. 4, 139ra183 (2012).

    Article  Google Scholar 

  17. 17.

    Smith, S. A. et al. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. mBio 00873–00813 (2013).

  18. 18.

    Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696–704 (2016).

    CAS  Article  Google Scholar 

  19. 19.

    Nybakken, G. E. et al. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437, 764–769 (2005).

    CAS  Article  Google Scholar 

  20. 20.

    Oliphant, T. et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11, 522–530 (2005).

    CAS  Article  Google Scholar 

  21. 21.

    Zhao, H. Y. et al. Structural basis of Zika virus-specific antibody protection. Cell 166, 1016–1027 (2016).

    CAS  Article  Google Scholar 

  22. 22.

    Barba-Spaeth, G. et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536, 48–53 (2016).

    CAS  Article  Google Scholar 

  23. 23.

    Kaufmann, B. et al. Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proc. Natl Acad. Sci. USA 107, 18950–18955 (2010).

    CAS  Article  Google Scholar 

  24. 24.

    Dang, M. et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell 5, 692–703 (2014).

    CAS  Article  Google Scholar 

  25. 25.

    Orso, G. et al. Homotypic fusion of ER membranes requires the dynamin-like GTPase atlastin. Nature 460, 978–983 (2009).

    CAS  Article  Google Scholar 

  26. 26.

    Minor, W. & Otwinowski, Z. in Methods in Enzymology, Macromolecular Crystallography (ed. Carter, C. W. Jr) 307–326 (Academic Press, New York, 1997); https://doi.org/10.1016/S0076-6879(97)76066-X.

  27. 27.

    Wang, X. et al. Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site. Proc. Natl Acad. Sci. USA 114, 770–775 (2017).

    CAS  Article  Google Scholar 

  28. 28.

    McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).

    CAS  Article  Google Scholar 

  29. 29.

    Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004).

    Article  Google Scholar 

  30. 30.

    Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).

    Article  Google Scholar 

  31. 31.

    Li, X. et al. Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. Nat. Methods 10, 584–590 (2013).

    CAS  Article  Google Scholar 

  32. 32.

    Ludtke, S. J., Baldwin, P. R. & Chiu, W. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128, 82–97 (1999).

    CAS  Article  Google Scholar 

  33. 33.

    Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).

    CAS  Article  Google Scholar 

  34. 34.

    Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Tang, G. et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38–46 (2007).

    CAS  Article  Google Scholar 

  36. 36.

    Pettersen, E. F. et al. UCSF Chimera—A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).

    CAS  Article  Google Scholar 

  37. 37.

    Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2009).

    Article  Google Scholar 

  38. 38.

    Barad, B. A. et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods 12, 943–946 (2015).

    CAS  Article  Google Scholar 

  39. 39.

    Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25, 402–408 (2001).

    CAS  Article  Google Scholar 

  40. 40.

    Xiao, C. & Rossmann, M. G. Interpretation of electron density with stereographic roadmap projections. J. Struct. Biol. 158, 182–187 (2007).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank Y. Chen, Z. Yang and B. Zhou for SPR technical support; X. Huang, B. Zhu and Z. Guo for cryo-EM technical support; and M.S. Diamond, S. Lok and D. Stuart for providing comments on the paper. The cryo-EM datasets were collected at the Center for Biological Imaging, Institute of Biophysics; the X-ray diffraction datasets were collected at beam line BL18U of the Shanghai Synchrotron Facility. Work was supported by the Ministry of Science and Technology 973 Project (grant no. 2014CB542800); the National Key Research and Development Program of China (no. 2016YFC1200400); the National Science Foundation, grant no. 81330036, no. 31570717, no. 81171557 and no.81520108019; the Strategic Priority Research Program of the Chinese Academy of Sciences, grant no. XDB08020200; and US NIH grants R01 AI1 12381 and R21 AI09464. X.W. is supported by the Young Elite Scientist sponsorship of CAST and program C of “One Hundred Talented People” of the Chinese Academy of Sciences.

Author information

Affiliations

Authors

Contributions

X.Q., Y.L., P.Y., N.W., Q.G. and X.Wa. performed the experiments; W.M., X.W., T.D. and F.Z. provided the reagents; X.Wa., Y.L., Z.X. and Z.R. designed the study; all authors analysed the data; and X.Wa., Y.L., Z.X., S.-L.L. and Z.R. wrote the manuscript.

Corresponding authors

Correspondence to Xiangxi Wang or Zhikai Xu or Zihe Rao.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Figures 1–15, Supplementary Tables 1–5 and Supplementary References.

Life Sciences Reporting Summary

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Qiu, X., Lei, Y., Yang, P. et al. Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies. Nat Microbiol 3, 287–294 (2018). https://doi.org/10.1038/s41564-017-0099-x

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing